Trials / Conditions / Anal Canal Cloacogenic Carcinoma
Anal Canal Cloacogenic Carcinoma
4 registered clinical trials studyying Anal Canal Cloacogenic Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients NCT04444921 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study NCT04166318 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Active Not Recruiting | Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer NCT03233711 | National Cancer Institute (NCI) | Phase 3 |
| Unknown | Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Local NCT02560298 | ECOG-ACRIN Cancer Research Group | Phase 2 |